Evidence map›Paper›PMID 33560295›Full record

ArticleBioinformatics (Oxford, England)2021

An OMICs-based meta-analysis to support infection state stratification.

Ashleigh C Myall, Simon Perkins, David Rushton, Jonathan David, Phillippa Spencer, Andrew R Jones, Philipp Antczak

Open access · hybridAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Diversity and Ecological Potentials of Marine Viruses Inhabiting Continental Shelf Seas.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ashleigh C MyallInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L697ZB, UK.
Simon PerkinsInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L697ZB, UK.
David RushtonDefence and Security Analysis Division, Defence Science and Technology laboratory (DSTL), Salisbury SP4 0JQ, UK.
Jonathan DavidChemical, Biological and Radiological Division, Defence Science and Technology laboratory (DSTL), Salisbury SP4 0JQ, UK.
Phillippa SpencerCyber and Information Systems Division, Defence Science and Technology laboratory (DSTL), Salisbury SP4 0JQ, UK.
Andrew R JonesInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L697ZB, UK.
Philipp AntczakInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L697ZB, UK.ORCID 0000-0001-9600-7757
University of Liverpool · GBDefence Science and Technology Laboratory · GB

Funding

Chem-Bio Diagnostics program HDTRA1-12-D-0003-0023Defense Threat Reduction Agency
6 · The paper itself

Abstract

motivationA fundamental problem for disease treatment is that while antibiotics are a powerful counter to bacteria, they are ineffective against viruses. Often, bacterial and viral infections are confused due to their similar symptoms and lack of rapid diagnostics. With many clinicians relying primarily on symptoms for diagnosis, overuse and misuse of modern antibiotics are rife, contributing to the growing pool of antibiotic resistance. To ensure an individual receives optimal treatment given their disease state and to reduce over-prescription of antibiotics, the host response can in theory be measured quickly to distinguish between the two states. To establish a predictive biomarker panel of disease state (viral/bacterial/no-infection), we conducted a meta-analysis of human blood infection studies using machine learning.

resultsWe focused on publicly available gene expression data from two widely used platforms, Affymetrix and Illumina microarrays as they represented a significant proportion of the available data. We were able to develop multi-class models with high accuracies with our best model predicting 93% of bacterial and 89% viral samples correctly. To compare the selected features in each of the different technologies, we reverse-engineered the underlying molecular regulatory network and explored the neighbourhood of the selected features. The networks highlighted that although on the gene-level the models differed, they contained genes from the same areas of the network. Specifically, this convergence was to pathways including the Type I interferon Signalling Pathway, Chemotaxis, Apoptotic Processes and Inflammatory/Innate Response. AVAILABILITY: Data and code are available on the Gene Expression Omnibus and github. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Identifiers

PMID33560295
PMCPMC8388022
OpenAlexW3126801790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.